Close
Close
Home - - Ethypharm Iberia adds Nefopam to its portfolio

Do you have
any question?

Contact us
13/05/2025

Ethypharm Iberia adds Nefopam to its portfolio

Ethypharm Iberia has signed a licensing agreement with Medochemie to commercialize Nefopam HCl 20mg/2ml injectable solution in Spain.

This analgesic provides an effective treatment for moderate to severe pain, addressing a real need for additional therapeutic options in the Spanish market.

This new product reinforces our ambition to grow our portfolio of essential medicines in pain, in line with Ethypharm’s mission to help improve patients’ lives.

Media enquiries

Please provide a valid state.
Please provide a valid state.
Please provide a valid state.
(+)
Please provide a valid state.
Please provide a valid state.
Please provide a valid state.
*All fields must be filled in

Thank you for your message!
We will examine it with utmost attention and get back to you shortly.